These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 23504624)
1. Signal regulatory protein α negatively regulates mast-cell activation following FcεRI aggregation. Pan YF; Dong LW; Wang M; Yang GZ; Zhang J; Li SX; Zhang B; Yang C; Li Z; Tan YX; Wang HY Eur J Immunol; 2013 Jun; 43(6):1598-607. PubMed ID: 23504624 [TBL] [Abstract][Full Text] [Related]
3. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE. Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196 [TBL] [Abstract][Full Text] [Related]
4. PICOT, protein kinase C theta-interacting protein, is a novel regulator of FcepsilonRI-mediated mast cell activation. Kato N; Motohashi S; Okada T; Ozawa T; Mashima K Cell Immunol; 2008 Jan; 251(1):62-7. PubMed ID: 18479680 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells. Miyata N; Gon Y; Nunomura S; Endo D; Yamashita K; Matsumoto K; Hashimoto S; Ra C Int Immunopharmacol; 2008 Jun; 8(6):874-80. PubMed ID: 18442792 [TBL] [Abstract][Full Text] [Related]
6. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells. Péterfy H; Tóth G; Pecht I; Erdei A Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698 [TBL] [Abstract][Full Text] [Related]
7. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses. Samayawardhena LA; Pallen CJ J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008 [TBL] [Abstract][Full Text] [Related]
8. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells. McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542 [TBL] [Abstract][Full Text] [Related]
9. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells. Mirzahosseini A; Dalmadi B; Csutora P Cell Immunol; 2013; 283(1-2):38-44. PubMed ID: 23850674 [TBL] [Abstract][Full Text] [Related]
10. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation. Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426 [TBL] [Abstract][Full Text] [Related]
11. Regulation of IgE-dependent zinc release from human mast cells. Nakashima-Kaneda K; Matsuda A; Mizuguchi H; Sasaki-Sakamoto T; Saito H; Ra C; Okayama Y Int Arch Allergy Immunol; 2013; 161 Suppl 2():44-51. PubMed ID: 23711853 [TBL] [Abstract][Full Text] [Related]
12. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production. Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342 [TBL] [Abstract][Full Text] [Related]
13. Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation. Nishida K; Yamasaki S; Hasegawa A; Iwamatsu A; Koseki H; Hirano T J Immunol; 2011 Jul; 187(2):932-41. PubMed ID: 21653832 [TBL] [Abstract][Full Text] [Related]
14. PI3Kgamma differentially regulates FcepsilonRI-mediated degranulation and migration of mast cells by and toward antigen. Endo D; Gon Y; Nunomura S; Yamashita K; Hashimoto S; Ra C Int Arch Allergy Immunol; 2009; 149 Suppl 1():66-72. PubMed ID: 19494508 [TBL] [Abstract][Full Text] [Related]
15. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. Klemm S; Gutermuth J; Hültner L; Sparwasser T; Behrendt H; Peschel C; Mak TW; Jakob T; Ruland J J Exp Med; 2006 Feb; 203(2):337-47. PubMed ID: 16432253 [TBL] [Abstract][Full Text] [Related]
16. Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions. Malaviya R; Uckun FM Biochem Biophys Res Commun; 1999 Apr; 257(3):807-13. PubMed ID: 10208864 [TBL] [Abstract][Full Text] [Related]
17. The role of Src family kinases in mast cell effector function. Furumoto Y; Gomez G; Gonzalez-Espinosa C; Kovarova M; Odom S; Ryan JJ; Rivera J Novartis Found Symp; 2005; 271():39-47; discussion 47-53, 95-9. PubMed ID: 16605127 [TBL] [Abstract][Full Text] [Related]
18. SR-BI regulates the synergistic mast cell response by modulating the plasma membrane-associated cholesterol pool. Capellmann S; Kauffmann M; Arock M; Huber M Eur J Immunol; 2024 Aug; 54(8):e2350788. PubMed ID: 38708681 [TBL] [Abstract][Full Text] [Related]
19. Shp2 activates Fyn and Ras to regulate RBL-2H3 mast cell activation following FcεRI aggregation. Fang X; Lang Y; Wang Y; Mo W; Wei H; Xie J; Yu M PLoS One; 2012; 7(7):e40566. PubMed ID: 22802969 [TBL] [Abstract][Full Text] [Related]
20. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells. MacNeil AJ; Yang YJ; Lin TJ J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]